Cargando…

Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis

Cancer metastasis is the major cause of cancer-related morbidity and mortality. It represents one of the greatest challenges in cancer therapy, both because of the ability of metastatic cells to spread into different organs, and because of the consequent heterogeneity that characterizes primary and...

Descripción completa

Detalles Bibliográficos
Autores principales: Şen, Özlem, Emanet, Melis, Ciofani, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610913/
https://www.ncbi.nlm.nih.gov/pubmed/33763992
http://dx.doi.org/10.1002/adhm.202002163
_version_ 1783605241799770112
author Şen, Özlem
Emanet, Melis
Ciofani, Gianni
author_facet Şen, Özlem
Emanet, Melis
Ciofani, Gianni
author_sort Şen, Özlem
collection PubMed
description Cancer metastasis is the major cause of cancer-related morbidity and mortality. It represents one of the greatest challenges in cancer therapy, both because of the ability of metastatic cells to spread into different organs, and because of the consequent heterogeneity that characterizes primary and metastatic tumors. Nanomaterials can potentially be used as targeting or detection agents owing to unique chemical and physical features that allow tailored and tunable theranostic functions. This review highlights nanomaterial-based approaches in the detection and treatment of cancer metastasis, with a special focus on the evaluation of nanostructure effects on cell migration, invasion, and angiogenesis in the tumor microenvironment.
format Online
Article
Text
id pubmed-7610913
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-76109132021-06-04 Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis Şen, Özlem Emanet, Melis Ciofani, Gianni Adv Healthc Mater Article Cancer metastasis is the major cause of cancer-related morbidity and mortality. It represents one of the greatest challenges in cancer therapy, both because of the ability of metastatic cells to spread into different organs, and because of the consequent heterogeneity that characterizes primary and metastatic tumors. Nanomaterials can potentially be used as targeting or detection agents owing to unique chemical and physical features that allow tailored and tunable theranostic functions. This review highlights nanomaterial-based approaches in the detection and treatment of cancer metastasis, with a special focus on the evaluation of nanostructure effects on cell migration, invasion, and angiogenesis in the tumor microenvironment. 2021-05-01 2021-03-24 /pmc/articles/PMC7610913/ /pubmed/33763992 http://dx.doi.org/10.1002/adhm.202002163 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposeshttps://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Şen, Özlem
Emanet, Melis
Ciofani, Gianni
Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
title Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
title_full Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
title_fullStr Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
title_full_unstemmed Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
title_short Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
title_sort nanotechnology-based strategies to evaluate and counteract cancer metastasis and neoangiogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610913/
https://www.ncbi.nlm.nih.gov/pubmed/33763992
http://dx.doi.org/10.1002/adhm.202002163
work_keys_str_mv AT senozlem nanotechnologybasedstrategiestoevaluateandcounteractcancermetastasisandneoangiogenesis
AT emanetmelis nanotechnologybasedstrategiestoevaluateandcounteractcancermetastasisandneoangiogenesis
AT ciofanigianni nanotechnologybasedstrategiestoevaluateandcounteractcancermetastasisandneoangiogenesis